Know Cancer

or
forgot password

Phase I Study of OSI-7904L in Combination With Cisplatin in Patients With Advanced Solid Tumors


Phase 1
18 Years
N/A
Not Enrolling
Both
Advanced Solid Tumors

Thank you

Trial Information

Phase I Study of OSI-7904L in Combination With Cisplatin in Patients With Advanced Solid Tumors


Inclusion Criteria:



- 18 years of age or older

- Advanced and/or metastatic solid tumor for which no effective therapy is available

- ECOG performance status 0-2

- Adequate bone marrow, hepatic and renal function

Exclusion Criteria:

- Patients with active or uncontrolled infections

- Neurotoxicity >= Grade 2

- Symptomatic brain metastases which are not stable

Type of Study:

Interventional

Study Design:

Masking: Open Label, Primary Purpose: Treatment

Authority:

United States: Food and Drug Administration

Study ID:

OSI-904-102

NCT ID:

NCT00116896

Start Date:

June 2003

Completion Date:

December 2004

Related Keywords:

  • Advanced Solid Tumors
  • Neoplasms

Name

Location

Vanderbilt Universtiy Medical CenterNashville, Tennessee  37232-6307
Institute for Drug DevelopmentCancer Therapy & Research CenterSan Antonio, Texas  78229